Rimegepant
Rimegepant is a pharmaceutical drug with 33 clinical trials. Currently 9 active trials ongoing. Historical success rate of 84.2%.
Success Metrics
Based on 16 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
9
Mid Stage
16
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
84.2%
16 of 19 finished
15.8%
3 ended early
9
trials recruiting
33
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Acute Migraine Treatment in the ED With Gepants
Clinical Trials (33)
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Acute Migraine Treatment in the ED With Gepants
Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use
ARISE-A Chinese Real-world Study of Rimegepant for the Acute Treatment of Migraine
Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey
A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.
Cluster Headache Treatment With Rimegepant
Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only)
Migraine Medication Effects on Urinary Symptoms
A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache
Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention
Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications
Rimegepant in Moderate Plaque-type Psoriasis
The R-E-V-I-V-A-L Study
Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients
A Clinical Trial of Rimegepant for Vestibular Migraine Evaluation: Pre-experiment
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 33